Laura Morelli

Dr. Laura Morelli

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2011 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
Laura MorelliLaura Morelli
Laura Morelli
LPLaura Poletti
Laura Poletti
LLLuigi Lay
Luigi Lay

18 August 2015 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
SSSara Sattin
Sara Sattin
JTJiahui Tao
Jiahui Tao
GVGerolamo Vettoretti
Gerolamo Vettoretti
EMElisabetta Moroni
Elisabetta Moroni
MPMarzia Pennati
Marzia Pennati
GCGiorgio Colombo
Giorgio Colombo

1 August 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
FBFrancesco Berti
Francesco Berti
ECEdmondo Campisi
Edmondo Campisi
CTChiara Toniolo
Chiara Toniolo
Laura MorelliLaura Morelli
Laura Morelli
SCStefano Crotti
Stefano Crotti
IMImmaculada Margarit
Immaculada Margarit
The Group B Streptococcus capsular polysaccharide type IX was isolated and purified, and the structure of its repeating unit was determined. Type IX capsule →4)[NeupNAc-α-(2→3)-Galp-β-(1→4)-GlcpNAc-β-(1→6)]-β-GlcpNAc-(1→4)-β-Galp-(1→4)-β-Glcp-(1→ appears most similar to types VII and V, although it contains two GlcpNAc residues. Genetic analysis identified differences in cpsM, cpsO, and cpsI gene sequences as responsible for the differentiation between the three capsular polysaccharide types, leading us to hypothesize that type V emerged from a recombination event in a type IX background.

6 May 2015 in ACS Chemical Biology
Verified
Journal Article
Closed access
ANAlberto Nilo
Alberto Nilo
Laura MorelliLaura Morelli
Laura Morelli
IPIrene Passalacqua
Irene Passalacqua
BBBarbara Brogioni
Barbara Brogioni
MAMartin Allan
Martin Allan
RARoberto Adamo
Roberto Adamo

26 February 2018 in ACS Chemical Biology
Verified
Journal Article
Closed access
DODavide Oldrini
Davide Oldrini
TFTimm Fiebig
Timm Fiebig
MRMaria Rosaria Romano
Maria Rosaria Romano
DPDaniela Proietti
Daniela Proietti
MBMonika Berger
Monika Berger
RARoberto Adamo
Roberto Adamo

13 October 2014 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
Laura MorelliLaura Morelli
Laura Morelli
DCDamiano Cancogni
Damiano Cancogni
MTMarta Tontini
Marta Tontini
ANAlberto Nilo
Alberto Nilo
SFSara Filippini
Sara Filippini
LLLuigi Lay
Luigi Lay
A vaccine to prevent infections from the emerging Neisseria meningitidis X (MenX) is becoming an urgent issue. Recently MenX capsular polysaccharide (CPS) fragments conjugated to CRM197 as carrier protein have been confirmed at preclinical stage as promising candidates for vaccine development. However, more insights about the minimal epitope required for the immunological activity of MenX CPS are needed. We report herein the chemical conjugation of fully synthetic MenX CPS oligomers (monomer, dimer, and trimer) to CRM197. Moreover, improvements in some crucial steps leading to the synthesis of MenX CPS fragments are described. Following immunization with the obtained neoglycoconjugates, the conjugated trimer was demonstrated as the minimal fragment possessing immunogenic activity, even though significantly lower than a pentadecamer obtained from the native polymer and conjugated to the same protein. This finding suggests that oligomers longer than three repeating units are possibly needed to mimic the activity of the native polysaccharide.